Pharmaceuticals & Biotech.
Pharmaceuticals & Biotech.
SECTOR | 12 Jan 2022
ICICI Securities Limited
Europe (select pack) is expected to grow 5.7% YoY mainly due to a fully normalised quarter for marketing activities partially offset by logistical challenges. API segment (select pack) is expected to grow ~4.2% YoY with healthy order book position. In APIs, it remains to be seen how much revenue the companies recognise in Q3FY22, given the input availability, cost volatility and their ability to pass on the same to customers. On the companies front, four out of 12 companies are likely to report 9%+ YoY growth. Key monitorables are: Divi's, which is likely to register around...
KRChoksey released a Sector Update report for Pharmaceuticals & Biotech. on 26 Mar, 2025.
More from Pharmaceuticals & Biotech.
Recommended